JD Healthcare’s H1 2022 Financial Report Shows Strong Growth in Revenue and Profits
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), reported robust financial results...
Everest Medicines CEO Resigns as Trodelvy Sale Completed
China-based biotech Everest Medicines (HKG: 1952) announced the resignation of CEO Dr. Kerry Blanchard, effective...
Shanghai Bao Pharma Raises USD 100M in Series B to Advance Drug Delivery Tech
Shanghai Bao Pharmaceuticals Co., Ltd has raised over USD 100 million in a Series B...
Lab Direct Raises USD 10M in Series A+ to Expand Digital Supply Chain Platform
Shanghai-based life science digital supply chain platform Lab Direct has raised USD 10 million in...
Health Plus Receives Strategic Investment from Meinian Onehealth to Drive Healthcare Innovation
Beijing-based Health Plus, a third-party digital managed healthcare service platform, has received strategic investment from...
Prismlab China Raises USD 29.1M in Series C for 3D Printing Expansion
Shanghai-based 3D printing solution provider Prismlab China Ltd has raised RMB 200 million (USD 29.1...
Junshi Biosciences’ TAB009/JS009 and JS110 Advance in Cancer Trials
Junshi Biosciences (HKG: 1877, SHA: 688180) has received approval from the National Medical Products Administration...
Illumina Opens First China Manufacturing Base for Gene Sequencers
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
Junshi Biosciences Gets NMPA Go-Ahead for TAB009/JS009 Cancer Study
Junshi Biosciences (HKG: 1877, SHA: 688180) has received approval from the National Medical Products Administration...
Illumina Opens First China Manufacturing Base for Gene Sequencers
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
Novartis to Spin Off Sandoz, Focus on Innovative Drugs
Swiss drugmaker Novartis announced plans to spin off its generic and biosimilar unit, Sandoz, to...
Clover Biopharmaceuticals’ SCB-2019 Vaccine Proves Effective in Teenagers
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) announced positive results from a global Phase II/III trial...
CStone Pharmaceuticals’ H1 2022 Revenue Jumps 229% on Drug Sales Growth
China-based CStone Pharmaceuticals (HKG: 2616) reported RMB 262 million (USD 49.4 million) in revenue for...
Innovent Biologics’ H1 2022 Revenue Rises 15.3% on Drug Sales Growth
China-based Innovent Biologics, Inc. (HKG: 1801) reported RMB 2.24 billion (USD 326.4 million) in revenue...
Akeso Biopharma’s H1 2022 Revenue Rises 26.8% on Penpulimab Sales
China-based Akeso Biopharma (HKG: 9926) reported RMB 163 million (USD 23.8 million) in revenue for...
Alpha Biopharma Completes EVEREST Trial for Zorifertinib in EGFR+ NSCLC with CNS Metastases
Shanghai-based Alpha Biopharma announced the completion of the last patient visit in the Phase II/III...
eTheRNA Raises EUR 39M in Series B2 to Expand mRNA Services and Leadership
Belgium-based biotech firm eTheRNA has completed a Series B2 financing round, raising EUR 39 million...
Sorrento Therapeutics’ Abivertinib Shows Positive Long-Term Data in NSCLC Trial
Sorrento Therapeutics Inc. (OTCMKTS: SRNE) announced positive long-term results for its third-generation EGFR inhibitor abivertinib...
Porton Biologics and Royaltech Med Partner on Bacterial and mRNA Drug Platforms
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has partnered with Suzhou...
NMPA Suspends UCB’s Keppra Over Labeling Issues, Prompting Recall
The National Medical Products Administration (NMPA) has suspended approval for UCB’s Keppra (levetiracetam) concentrated solution...